1 64350sek
-1,9 %
Date:2026-10-16Time:18:00:00Latest report:Q2-2026List:Large CapTicker:AZN
Market Cap:2 549 156 msekEnterprise Value:2 810 224 msekNet Sales:61 366 musdEarnings:10 446 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 643,50
MA50:1 581,80
MA200:1 703,80
Price/MA200:-3,5 %
RSI (14):57,2
Price/MA50:3,9 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.